{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:29:50Z","timestamp":1788492590212,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jsbmb.2026.106974","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:12:15Z","timestamp":1772125935000},"page":"106974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A novel thiadiazole-steroid hybrid as a CYP19A1 inhibitor: Synthesis, molecular interaction analysis and assessment of steroid receptor signaling"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-838X","authenticated-orcid":false,"given":"Yulia A.","family":"Volkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaraslau U.","family":"Dzichenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila V.","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Malakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis Y.","family":"Uvarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoly Y.","family":"Chursin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurii A.","family":"Sidunets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya V.","family":"Chebotkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Usanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor B.","family":"Bogdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvina I.","family":"Khamidullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana I.","family":"Salnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Scherbakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Zavarzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.106974_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2026.106974_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","article-title":"Aromatase--a brief overview","volume":"64","author":"Simpson","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1249160","article-title":"Aromatase inhibitors: the journey from the state of the art to clinical open questions","volume":"13","author":"Generali","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","article-title":"Aromatase, aromatase inhibitors, and breast cancer","volume":"125","author":"Chumsri","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106729","article-title":"The current landscape of aromatase inhibitors for the treatment of estrogen receptor-positive breast carcinoma","volume":"250","author":"Bhutani","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib6","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cancers17172726","article-title":"Aromatase inhibitors as adjuvant therapy in early breast cancer: insights into toxicities and their management","volume":"17","author":"Nardin","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2026.106974_bib7","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives","volume":"142","author":"Simpson","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2026.106974_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2026.106974_bib9","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1067\/mjd.2001.117432","article-title":"Estrogen production and action","volume":"45","author":"Nelson","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1261283","article-title":"The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib11","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/s41467-022-30898-0","article-title":"Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor","volume":"13","author":"Scabia","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jsbmb.2026.106974_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/ijms22020756","article-title":"A closer look at estrogen receptor mutations in breast cancer and their implications for estrogen and antiestrogen responses","volume":"22","author":"Clusan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2026.106974_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10815-016-0727-z","article-title":"Epigenetic alterations of CYP19A1 gene in Cumulus cells and its relevance to infertility in endometriosis","volume":"33","author":"Hosseini","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jsbmb.2026.106974_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2009.05.041","article-title":"Elevated aromatase expression correlates with cervical carcinoma progression","volume":"114","author":"Veerapaneni","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/j.1875-9114.1981.tb03557.x","article-title":"Aminoglutethimide: review of pharmacology and clinical use","volume":"1","author":"Santen","year":"1981","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jsbmb.2026.106974_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103818","article-title":"Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer","volume":"78","author":"Dai","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.jsbmb.2026.106974_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis","volume":"103","author":"Amir","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2026.106974_bib19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI41680","article-title":"Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer","volume":"120","author":"Miller","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jsbmb.2026.106974_bib20","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2026.106974_bib21","first-page":"198","article-title":"New insights into acquired endocrine resistance of breast cancer","volume":"2","author":"Fan","year":"2019","journal-title":"Cancer drug resistance (Alhambra Calif. )"},{"key":"10.1016\/j.jsbmb.2026.106974_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001703-200202000-00002","article-title":"Role of antiestrogens and aromatase inhibitors in breast cancer treatment","volume":"14","author":"Bentrem","year":"2002","journal-title":"Curr. Opin. Obstet. & Gynecol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib23","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1210\/en.2018-00263","article-title":"Successful targeted therapies for breast cancer: the worcester foundation and future opportunities in women's health","volume":"159","author":"Abderrahman","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2026.106974_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.09.038","article-title":"Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer","volume":"105","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib25","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2174\/1871520620666200627204105","article-title":"Aromatase inhibitors for the treatment of breast cancer: a journey from the scratch","volume":"20","author":"Ratre","year":"2020","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.steroids.2006.10.002","article-title":"Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives","volume":"72","author":"Ga\u0161i","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106974_bib27","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1021\/jm300930n","article-title":"Novel aromatase inhibitors by structure-guided design","volume":"55","author":"Ghosh","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib28","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/molecules24091783","article-title":"Synthesis, biological evaluation and docking studies of 13-epimeric 10-fluoro-and 10-chloroestra-1, 4-dien-3-ones as potential aromatase inhibitors","volume":"24","author":"J\u00f3j\u00e1rt","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2026.106974_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109173","article-title":"Synthesis, antiproliferative evaluation and in silico studies of a novel steroidal spiro morpholinone","volume":"192","author":"Cobos-Ontiveros","year":"2023","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106974_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202401315","article-title":"Novel coumarin-steroid\/terpenoid hybrids: in vitro and in silico anticancer studies","volume":"21","author":"Mart\u00ednez-Lara","year":"2024","journal-title":"Chem. & Biodivers."},{"key":"10.1016\/j.jsbmb.2026.106974_bib31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1248\/cpb.56.1304","article-title":"Structure\u2013activity relationships of estrogen derivatives as aromatase inhibitors. Effects of heterocyclic substituents","volume":"56","author":"Numazawa","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2026.106974_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bioorg.2012.08.005","article-title":"Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids","volume":"45","author":"Bansal","year":"2012","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136903","article-title":"Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors","volume":"1296","author":"Demiraran","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jsbmb.2026.106974_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1570180813666160722123045","article-title":"Zinc tetrafluoroborate catalyzed synthesis, molecular docking and cytotoxicity of pyrrolidinyl aminophosphonates","volume":"14","author":"Santhisudha","year":"2017","journal-title":"Lett. Drug Des. & Discov."},{"key":"10.1016\/j.jsbmb.2026.106974_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103142","article-title":"Novel steroidal 1, 3, 4-thiadiazines: synthesis and biological evaluation in androgen receptor-positive prostate cancer 22Rv1 cells","volume":"91","author":"Komendantova","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fphar.2017.00979","article-title":"Steroidal pyrimidines and dihydrotriazines as novel classes of anticancer agents against hormone-dependent breast cancer cells","volume":"8","author":"Scherbakov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.steroids.2016.06.001","article-title":"Synthesis and antiproliferative activity evaluation of steroidal imidazo [1, 2-a] pyridines","volume":"113","author":"Rassokhina","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106974_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.steroids.2018.06.013","article-title":"Synthesis and evaluation of the antiproliferative activity of benzylidenes of 16-dehydroprogesterone series","volume":"138","author":"Scherbakov","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2026.106974_bib39","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1039\/D0OB01241F","article-title":"Fe (iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents","volume":"18","author":"Samanta","year":"2020","journal-title":"Org. & Biomol. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106309","article-title":"Discovery of highly potent proapoptotic antiestrogens in a series of androst-5, 16-dienes D-modified with imidazole-annulated pendants","volume":"231","author":"Birukova","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib41","doi-asserted-by":"crossref","first-page":"42863","DOI":"10.1039\/C6RA06881B","article-title":"Access to steroidal pyridazines via modified thiohydrazides","volume":"6","author":"Volkova","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.jsbmb.2026.106974_bib42","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1039\/D4MD00153B","article-title":"Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells","volume":"15","author":"Volkova","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300651","article-title":"Exploration and biological evaluation of 20-vinyl pregnenes: a step forward toward selective modulators of the estrogen receptor \u03b1 signaling for breast cancer treatment","volume":"357","author":"Malakhova","year":"2024","journal-title":"Arch. der Pharm."},{"key":"10.1016\/j.jsbmb.2026.106974_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2023.133746","article-title":"Simple approach towards phosphorus-substituted spiro 1, 3, 4-thiadiazolines","volume":"150","author":"Kozlov","year":"2024","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jsbmb.2026.106974_bib45","doi-asserted-by":"crossref","first-page":"15885","DOI":"10.1039\/D5NJ01910A","article-title":"Effects of phosphorus (V)-substituted 1, 3, 4-thiadiazoles on electronic properties of BODIPY fluorophore","volume":"49","author":"Uvarov","year":"2025","journal-title":"N. J. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib46","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1002\/adsc.201900067","article-title":"Synthesis of Phosphoryl Thioamides via Three-Component Reaction of Phosphinic Chlorides with Amines and Sulfur","volume":"361","author":"Kozlov","year":"2019","journal-title":"Adv. Synth. & Catal."},{"key":"10.1016\/j.jsbmb.2026.106974_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jsbmb.2026.106974_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/fft2.44","article-title":"Guidelines for cell viability assays","volume":"1","author":"Kamiloglu","year":"2020","journal-title":"Food Front."},{"key":"10.1016\/j.jsbmb.2026.106974_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2015.07.018","article-title":"Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and\u2013resistant breast cancer cells","volume":"161","author":"Chan","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1432-1033.2001.01886.x","article-title":"Evaluation of the mechanism of aromatase cytochrome P450: A site-directed mutagenesis study","volume":"268","author":"Kao","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib51","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1186\/s12885-025-15321-3","article-title":"Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling","volume":"25","author":"Ojedele","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jsbmb.2026.106974_bib52","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/bi400669h","article-title":"Structural basis for the functional roles of critical residues in human cytochrome P450 aromatase","volume":"52","author":"Lo","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2026.106974_bib53","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00894-010-0667-y","article-title":"Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors","volume":"16","author":"Roy","year":"2010","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jsbmb.2026.106974_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104508","article-title":"Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up","volume":"10","author":"Matsumoto","year":"2025","journal-title":"ESMO Open"},{"issue":"15","key":"10.1016\/j.jsbmb.2026.106974_bib55","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.3390\/cancers15194689","article-title":"Estrogen Receptor Signaling in Breast Cancer","volume":"15","author":"Miziak","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2026.106974_bib56","first-page":"3147","article-title":"The story of MCF-7 breast cancer cell line: 40 years of experience in research","volume":"35","author":"Com\u015fa","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jsbmb.2026.106974_bib57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells13231959","article-title":"Standardized protocol for resazurin-based viability assays on A549 cell line for improving cytotoxicity data reliability","volume":"13","author":"Petiti","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jsbmb.2026.106974_bib59","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.3390\/pharmaceutics14122829","article-title":"Design, synthesis and in vitro investigation of cabozantinib-based PROTACs to target c-met kinase","volume":"14","author":"Sachkova","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jsbmb.2026.106974_bib60","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/spmg.1.2.16606","article-title":"Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits","volume":"1","author":"Mruk","year":"2011","journal-title":"Spermatogenesis"},{"key":"10.1016\/j.jsbmb.2026.106974_bib62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jsbmb.2026.106974_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Chemin.."},{"key":"10.1016\/j.jsbmb.2026.106974_bib64","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2026.106974_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105777","article-title":"Modified bile acids and androstanes\u2014Novel promising inhibitors of human cytochrome P450 17A1","volume":"205","author":"Dzichenka","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jsbmb.2026.106974_bib68","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1083\/jcb.66.1.188","article-title":"Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining","volume":"66","author":"Krishan","year":"1975","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jsbmb.2026.106974_bib69","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jsbmb.2026.106974_bib70","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902023e22540","article-title":"Antiproliferative effects of 13\u03b1\/\u03b2-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ER\u03b1","volume":"59","author":"Scherbakov","year":"2023","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.jsbmb.2026.106974_bib71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10637-023-01332-z","article-title":"Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells","volume":"41","author":"Scherbakov","year":"2023","journal-title":"Investig. N. Drugs"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:52:29Z","timestamp":1777949549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":71,"alternative-id":["S0960076026000403"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106974","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel thiadiazole-steroid hybrid as a CYP19A1 inhibitor: Synthesis, molecular interaction analysis and assessment of steroid receptor signaling","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106974"}}